Skip to main content
. Author manuscript; available in PMC: 2008 May 18.
Published in final edited form as: J Mol Biol. 2007 Mar 6;368(5):1392–1402. doi: 10.1016/j.jmb.2007.02.081

Figure 3.

Figure 3

Architecture of the antibody combining site of RS2-1G9. The CDRs of light and heavy chains are highlighted in yellow and blue, respectively. The lactam 3 is shown in pink. The tip of the CDR H3 loop bends over the ligand and largely seals it from bulk solvent.